Research from Edith Cowan University (ECU) indicates that sleep patterns and genetics may interact to affect early brain and cognitive changes related to Alzheimer's disease. The study, conducted by ECU's Centre for Precision Health (CPH), focused on the aquaporin-4 (AQP4) gene, which regulates fluid movement in the brain and supports its waste-clearing system.

Read More

The brain's waste-removal activities intensify during sleep, helping eliminate potentially harmful proteins, including those linked to Alzheimer's disease. The research revealed that the impact of sleep varies based on the specific version of the AQP4 gene individuals possess.

Dr. Ayeisha Milligan Armstrong noted, "Our study shows that individuals carrying certain AQP4 variants exhibited faster grey matter loss when they reported shorter sleep." She emphasized that genetic predispositions interact significantly with lifestyle factors like sleep, highlighting the importance of sleep as a modifiable risk factor.

Grey matter is crucial for essential brain functions such as memory and decision-making, and a decrease in its volume can indicate structural brain changes. The study analyzed 13 common AQP4 variants, alongside participants' self-reported sleep patterns, brain imaging, and cognitive performance data.

The findings showed that shorter sleep duration correlated with more rapid grey matter decline in some participants, while longer sleep onset times were associated with lower brain volume in others. Cognitive performance also varied, suggesting that the genetic background modifies responses to sleep quality.

Dr. Tenielle Porter remarked on the established link between poor sleep and Alzheimer's risk, asserting the need for personalized prevention strategies rather than a one-size-fits-all approach. However, she cautioned that the findings require validation in larger and more diverse groups before recommending genetic testing.

The study's insights imply that individuals with similar overall Alzheimer's risk might respond differently to poor sleep based on their genetic make-up. The researchers advocated for clinical trials that incorporate genetic factors to assess whether improved sleep habits can mitigate inherited vulnerabilities and positively impact long-term brain health related to Alzheimer's.

CPH Director Professor Simon Laws stated, "Identifying who is most vulnerable, and who stands to benefit most from specific lifestyle changes, is where precision health should target efforts, rather than treating everyone at risk of Alzheimer's equivalently."

This study, titled "Evidence for Direct and Sleep-Moderated Relationships between Aquaporin-4 Genetic Variants and Alzheimer's Disease Phenotypes," is available in Alzheimer's & Dementia, the Journal of the Alzheimer's Association.